{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02610296: Phase 3 Interventional Completed Delayed Graft Function
(2016)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:cavrotolimod [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:mulnitorsen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03508947: Phase 1 Interventional Completed Duchenne Muscular Dystrophy
(2018)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03373786: Phase 1 Interventional Completed Alport Syndrome
(2017)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03334617: Phase 2 Interventional Active, not recruiting Non-Small Cell Lung Cancer
(2017)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:atesidorsen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01743807: Phase 1 Interventional Terminated Relapsed Acute Lymphoblastic Leukemia
(2014)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02658175: Phase 3 Interventional Completed Familial Chylomicronemia Syndrome
(2015)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00017407: Phase 3 Interventional Completed Lung Cancer
(2000)
Source URL:
Class:
NUCLEIC ACID